Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126369431 | 12636943 | 1 | I | 20160803 | 20160809 | 20160809 | EXP | US-ABBVIE-16P-163-1693212-00 | ABBVIE | FACTORS CONTRIBUTING TO ACHIEVING REMISSION AND DEVELOPING AN ACUTE CONDITION IN CHILDREN WITH JUVENILE IDIOPATHIC ART. | 56.00 | YR | M | Y | 136.00000 | KG | 20160809 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126369431 | 12636943 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | Y | UNKNOWN | 50662 | 500 | MG | TABLET | BID | |||||
| 126369431 | 12636943 | 2 | I | EVEROLIMUS | EVEROLIMUS | 1 | Oral | Y | UNKNOWN | 0 | 10 | MG | QD | ||||||
| 126369431 | 12636943 | 3 | I | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | U | UNKNOWN | 0 | 40 | MG | |||||||
| 126369431 | 12636943 | 4 | C | AMOXICILLIN. | AMOXICILLIN | 1 | Oral | 0 | 500 | MG | BID | ||||||||
| 126369431 | 12636943 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 126369431 | 12636943 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | 200 | UG | QD | ||||||||
| 126369431 | 12636943 | 7 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126369431 | 12636943 | 1 | Helicobacter infection |
| 126369431 | 12636943 | 2 | Renal cell carcinoma |
| 126369431 | 12636943 | 3 | Product used for unknown indication |
| 126369431 | 12636943 | 4 | Helicobacter infection |
| 126369431 | 12636943 | 5 | Helicobacter infection |
| 126369431 | 12636943 | 6 | Product used for unknown indication |
| 126369431 | 12636943 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126369431 | 12636943 | OT |
| 126369431 | 12636943 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126369431 | 12636943 | Acute kidney injury | |
| 126369431 | 12636943 | Drug interaction | |
| 126369431 | 12636943 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |